Network Approaches for Precision Oncology

Shraddha Pai1

  • 1Ontario Institute for Cancer Research, University of Toronto, Toronto, ON, Canada. shraddha.pai@utoronto.ca.

Insights

Network-based computational methods are advancing precision oncology by integrating multi-omic tumor data. Patient similarity networks (PSNs) are key for stratifying and classifying patients, improving treatment design.

Area of Science:

  • Computational biology
  • Genomics
  • Oncology

Background:

  • Multi-omic tumor profiling and genomic regulatory networks offer new avenues for precision oncology.
  • Integrating heterogeneous data sources computationally is crucial for advancing personalized cancer treatments.
  • Genomic models benefit from interpretability and prior knowledge integration to minimize ungeneralizable models and optimize treatment strategies.

Purpose of the Study:

  • To introduce network-based approaches for integrating multi-modal data in precision oncology.
  • To highlight the application of patient similarity networks (PSNs) for patient stratification and classification.
  • To discuss methods for inferring driver mutations and future challenges in the field.

Main Methods:

  • Utilizing network-based approaches to integrate diverse data sources.
  • Employing patient similarity networks (PSNs) for patient stratification and classification.
  • Developing strategies for inferring driver mutations from individual patient mutation data.

Main Results:

  • Network-based methods enable the integration of multi-modal data for improved patient stratification.
  • Patient similarity networks (PSNs) show promise in classifying patients for tailored treatments.
  • Strategies for driver mutation inference are discussed in the context of sparse genetic data.

Conclusions:

  • Network-based approaches, particularly PSNs, are vital for advancing precision oncology.
  • Effective integration of multi-omic data and prior knowledge is essential for rational treatment design.
  • Overcoming current challenges will pave the way for future clinical applications in personalized cancer care.